Skip to main content

Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Projects

European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: EUROPEAN COMMISSION
Funding: 463200
Reference: EUSTROKE_FP7HEALTH2007
Duration: 01/03/2008 - 31/08/2013

Angiopatía amieloide cerebral (AAC)

IP: Joan Montaner Villalonga
Collaborators: Maria Mar Hernandez Guillamon
Funding agency: Instituto de Salud Carlos III
Funding: 148377.88
Reference: CD06/00028
Duration: 01/01/2007 - 31/12/2010

Influencia de las Células Endoteliales Progenitoras sobre la Modulación Espacio-Temporal de la Angiogénesis y la Vasculogénesis tras el Ictus Isquémico Humano

IP: José Alvarez Sabin
Collaborators: Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 240185
Reference: PI060471
Duration: 01/01/2007 - 31/05/2010

Participación de sistemas proteolíticos en la progresión de la angiopatía amiloide cerebral

IP: Mercè Boada Rovira
Collaborators: Francesc Pujadas Navinés, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 161535
Reference: PI070737
Duration: 01/01/2008 - 30/06/2011

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Milagros Suito Alcantara

Milagros Suito Alcantara

Predoctoral researcher
Read more
Janna Anthonina Slabbekoorn

Janna Anthonina Slabbekoorn

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Maria Francesca Cortese

Maria Francesca Cortese

Main researcher
Microbiology
Read more
Efráin Santiago Cordero Vázquez

Efráin Santiago Cordero Vázquez

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.